| Literature DB >> 24962035 |
M Lionello1, P Stritoni, M C Facciolo, A Staffieri, A Martini, A Mazzoni, E Zanoletti, G Marioni.
Abstract
Temporal bone carcinoma is an uncommon aggressive malignancy. Its low incidence and the absence of a globally accepted staging system still make it difficult to compare different centers' approaches and results. In this review of the main available studies dealing with temporal bone carcinoma since 1995, we consider its rational preoperative staging and assessment, compare the effectiveness of different treatments by tumor stage, and outline the main actuarial prognostic factors.Entities:
Keywords: biomarkers; carcinoma; diagnosis; prognosis; temporal bone; treatment
Mesh:
Substances:
Year: 2014 PMID: 24962035 DOI: 10.1002/jso.23660
Source DB: PubMed Journal: J Surg Oncol ISSN: 0022-4790 Impact factor: 3.454